Literature DB >> 17899234

Antifungal activity of a novel chromene dimer.

L Abrunhosa1, M Costa, F Areias, A Venâncio, F Proença.   

Abstract

The activity on Aspergillus spp. growth and on ochratoxin A production of two novel chromene dimers (3) was evaluated. The results of the bioassays indicate that the chromene dimer 3a inhibited mycelia growth by approximately 50% (EC(50)) at 140.1 micromol L(-1) for A. niger, 384.2 micromol L(-1) for A. carbonarius, 69.1 micromol L(-1) for A. alliaceus and 559.1 micromol L(-1) for A. ochraceus. When applied at concentrations of 2 mmol L(-1), 3a totally inhibited the growth of all Aspergillus spp. tested. Furthermore, ochratoxin A production by A. alliaceus was reduced by about 94% with a 200 micromol L(-1) solution of this compound. A moderate inhibitory effect was observed for the analogous structure 3b on ochratoxin A production but not in mycelia growth. No inhibition was registered for compounds 2a and 2b, used as synthetic precursors of the dimeric species 3.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17899234     DOI: 10.1007/s10295-007-0255-z

Source DB:  PubMed          Journal:  J Ind Microbiol Biotechnol        ISSN: 1367-5435            Impact factor:   3.346


  12 in total

Review 1.  Recent progress in the development of coumarin derivatives as potent anti-HIV agents.

Authors:  Donglei Yu; Madoka Suzuki; Lan Xie; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2003-05       Impact factor: 12.944

2.  Synthesis of coumarin derivatives with cytotoxic, antibacterial and antifungal activity.

Authors:  Khalid Mohammed Khan; Zafar S Saify; Muhammad Zarrar Khan; Iqbal M Choudhary; Shahnaz Perveen; Zahid H Chohan; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2004-08       Impact factor: 5.051

3.  Synthesis and in vitro selective anti-Helicobacter pylori activity of N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides.

Authors:  Franco Chimenti; Bruna Bizzarri; Adriana Bolasco; Daniela Secci; Paola Chimenti; Simone Carradori; Arianna Granese; Daniela Rivanera; Daniela Lilli; M Maddalena Scaltrito; M Immacolata Brenciaglia
Journal:  Eur J Med Chem       Date:  2006-01-10       Impact factor: 6.514

Review 4.  Chemistry and biological activity of natural and synthetic prenyloxycoumarins.

Authors:  Massimo Curini; Giancarlo Cravotto; Francesco Epifano; Giovanni Giannone
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

5.  Biochemical characterization of ochratoxin A-producing strains of the genus Penicillium.

Authors:  T O Larsen; A Svendsen; J Smedsgaard
Journal:  Appl Environ Microbiol       Date:  2001-08       Impact factor: 4.792

6.  Impact of fungicides on Aspergillus carbonarius growth and ochratoxin A production on synthetic grape-like medium and on grapes.

Authors:  N Bellí; S Marín; V Sanchis; A J Ramos
Journal:  Food Addit Contam       Date:  2006-10

Review 7.  Simple coumarins and analogues in medicinal chemistry: occurrence, synthesis and biological activity.

Authors:  F Borges; F Roleira; N Milhazes; L Santana; E Uriarte
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

Review 8.  Recent advances in coumarins and 1-azacoumarins as versatile biodynamic agents.

Authors:  Manohar V Kulkarni; Geeta M Kulkarni; Chao-Hsiung Lin; Chung-Ming Sun
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

9.  Penicillium verrucosum in wheat and barley indicates presence of ochratoxin A.

Authors:  F Lund; J C Frisvad
Journal:  J Appl Microbiol       Date:  2003       Impact factor: 3.772

10.  Black Aspergillus species as ochratoxin A producers in Portuguese wine grapes.

Authors:  Rita Serra; Luís Abrunhosa; Zofia Kozakiewicz; Armando Venâncio
Journal:  Int J Food Microbiol       Date:  2003-11-15       Impact factor: 5.277

View more
  1 in total

1.  Efficient Synthesis and Antimicrobial Evaluation of Pyrazolopyranopyrimidines in the Presence of SBA-Pr-SO3H as a Nanoporous Acid Catalyst.

Authors:  Ghodsi Mohammadi Ziarani; Faezeh Aleali; Negar Lashgari; Alireza Badiei; Ali Abolhasani Soorki
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.